🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Global Cord Blood Corporation Shares Spike On Potential HIV Cure Reports

Published 02/16/2022, 02:50 AM
© Reuters.
CORBF
-

By Sam Boughedda

Investing.com -- Shares of Global Cord Blood Corp (NYSE:CO) spiked Tuesday after reports that a woman in New York appears to have been cured of an HIV infection.

According to a report in the Wall Street Journal, the woman has shown no signs of the virus in testing since she stopped treatment in October 2020 after a transplant of stem cells with a rare genetic mutation that blocks HIV invasion.

The transplant of stem cells is said to be from an adult relative and umbilical-cord blood from a newborn the woman is not related to.

Global Cord Blood Corp engages in the provision of cord blood banking services, providing a cord blood processing and storage service.

According to WSJ, the doctors said they believe the woman's HIV is in long-term remission, suggesting a cure if it holds.

Global Blood Corp shares hit a high of $5.50 on the news, after opening up the session at $4.19.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.